Lacosamide is a functionalized amino acid anticonvulsant medication primarily indicated for the adjunctive treatment of partial-onset seizures in adults and children with epilepsy. By selectively enhancing… Read more













![Chemical structure of N-[2-[[(Phenylmethoxy)carbonyl]amino]ethyl]-D-alanine ethyl ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2231404-56-9-N-2-Phenylmethoxycarbonylaminoethyl-D-alanine-ethyl-ester.png&w=3840&q=75)













Lacosamide is a functionalized amino acid anticonvulsant medication primarily indicated for the adjunctive treatment of partial-onset seizures in adults and children with epilepsy. By selectively enhancing the slow inactivation of voltage-gated sodium channels, it helps stabilize neuronal membranes and reduce hyperexcitability. This category provides an extensive range of reference standards, including the active pharmaceutical ingredient, various pharmacopeial and non-pharmacopeial impurities, and metabolites essential for rigorous pharmaceutical analysis. Analytical laboratories utilize these high-quality materials for impurity profiling, method validation, and consistent quality control throughout the drug manufacturing process. Additionally, stable isotope labelled compounds are available to serve as internal standards in quantitative analytical techniques, such as mass spectrometry, ensuring the accuracy and reproducibility of pharmacokinetic and bioanalytical studies. These standards are critical for confirming identity and concentration, supporting compliance with regulatory requirements during the development and testing of lacosamide-based therapies.